Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acupoint Photodynamic Therapy and Dingkun Dan for Diminished Ovarian Reserve
NCT07376824Phase 3Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Dec 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dingkundan in Diminished Ovarian Reserve (DOR), sponsored by Peking Union Medical College Hospital. Started Dec 2024; status: recruiting.
02
Drugs
dingkundan
03
Conditions
Diminished Ovarian Reserve (DOR)
Beyond the preview
Go deeper on NCT07376824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07376824.